1. Home
  2. EVGN vs BHAT Comparison

EVGN vs BHAT Comparison

Compare EVGN & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • BHAT
  • Stock Information
  • Founded
  • EVGN 1999
  • BHAT 2010
  • Country
  • EVGN Israel
  • BHAT China
  • Employees
  • EVGN N/A
  • BHAT N/A
  • Industry
  • EVGN Agricultural Chemicals
  • BHAT Recreational Games/Products/Toys
  • Sector
  • EVGN Industrials
  • BHAT Consumer Discretionary
  • Exchange
  • EVGN Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • EVGN 11.4M
  • BHAT 12.7M
  • IPO Year
  • EVGN N/A
  • BHAT 2019
  • Fundamental
  • Price
  • EVGN $1.21
  • BHAT $1.67
  • Analyst Decision
  • EVGN Strong Buy
  • BHAT
  • Analyst Count
  • EVGN 1
  • BHAT 0
  • Target Price
  • EVGN $3.50
  • BHAT N/A
  • AVG Volume (30 Days)
  • EVGN 90.5K
  • BHAT 85.4K
  • Earning Date
  • EVGN 08-19-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • EVGN N/A
  • BHAT N/A
  • EPS Growth
  • EVGN N/A
  • BHAT N/A
  • EPS
  • EVGN N/A
  • BHAT N/A
  • Revenue
  • EVGN $6,765,000.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • EVGN N/A
  • BHAT N/A
  • Revenue Next Year
  • EVGN $113.18
  • BHAT N/A
  • P/E Ratio
  • EVGN N/A
  • BHAT N/A
  • Revenue Growth
  • EVGN N/A
  • BHAT N/A
  • 52 Week Low
  • EVGN $0.95
  • BHAT $1.61
  • 52 Week High
  • EVGN $4.29
  • BHAT $72.80
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 45.00
  • BHAT 38.80
  • Support Level
  • EVGN $1.18
  • BHAT $1.75
  • Resistance Level
  • EVGN $1.36
  • BHAT $1.79
  • Average True Range (ATR)
  • EVGN 0.07
  • BHAT 0.09
  • MACD
  • EVGN -0.00
  • BHAT -0.01
  • Stochastic Oscillator
  • EVGN 34.78
  • BHAT 9.27

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: